Barbieri E J, Orzechowski R F, Rossi G V
J Pharmacol Exp Ther. 1977 Jun;201(3):769-77.
A method was developed for extracting and measuring nanogram quantities of prostaglandin E2 (PGE2) from carrageenan-induced abscess in the rat. PGE2 concentration, quantitated by radioimmunoassay, was 42.5 and 92.9 ng/g of abscess in two studies. Anti-inflammatory activity, based on reduction in abscess weight, was observed with indomethacin, phenylbutazone, SC-19220 and A-22981; however, only indomethacin (10 mg/kg i.p.) significantly reduced PGE2 levels in the abscess tissue. Dose-related anti-inflammatory activity of indomethacin (1-10 mg/kg i.p.) was directly correlated with reductions of PGE2 content in the abscess. These data support the theory that the anti-inflammatory activity of indomethacin in the carrageenan abscess model involves inhibition of prostaglandin formation. Dose-related suppression of abscess formation by SC-19220 (7.5-30 mg/kg i.p.) was not related to changes in PGE2 levels at the inflammatory site, which suggests that the anti-inflammatory mechanism of SC-19220 is not mediated via inhibition of prostaglandin synthesis.
已开发出一种从角叉菜胶诱导的大鼠脓肿中提取并测量纳克量前列腺素E2(PGE2)的方法。在两项研究中,通过放射免疫测定法定量的PGE2浓度分别为每克脓肿42.5纳克和92.9纳克。观察到吲哚美辛、保泰松、SC - 19220和A - 22981具有基于脓肿重量减轻的抗炎活性;然而,只有吲哚美辛(10毫克/千克腹腔注射)能显著降低脓肿组织中的PGE2水平。吲哚美辛(1 - 10毫克/千克腹腔注射)的剂量相关抗炎活性与脓肿中PGE2含量的降低直接相关。这些数据支持这样一种理论,即吲哚美辛在角叉菜胶脓肿模型中的抗炎活性涉及对前列腺素形成的抑制。SC - 19220(7.5 - 30毫克/千克腹腔注射)对脓肿形成的剂量相关抑制作用与炎症部位PGE2水平的变化无关,这表明SC -